Clinical Trial Update: A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331) [Phase 3]

View source ↗

Summary

A 52-week Phase 3 trial evaluating losartan with or without hydrochlorothiazide on plasma glucose, metabolic parameters, and blood pressure in hypertensive pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Metabolic Syndrome

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Losartan (losartan)

Snippet

Sponsor: Organon and Co | Conditions: Hypertension, Metabolic Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-06-23